Stoke Therapeutics, Inc. STOK Interest receivable on interest rate and cross currency swaps
Interest receivable on interest rate and cross currency swaps at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestReceivableCurrent.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s interest receivable on interest rate and cross currency swaps.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s interest receivable on interest rate and cross currency swaps?
- Stoke Therapeutics, Inc. (STOK) reported interest receivable on interest rate and cross currency swaps of $1.69M in Q1 2026.
- How has Stoke Therapeutics, Inc.'s interest receivable on interest rate and cross currency swaps changed year-over-year?
- Stoke Therapeutics, Inc.'s interest receivable on interest rate and cross currency swaps increased by 178.9% year-over-year, from $606K to $1.69M.
- What is the long-term trend for Stoke Therapeutics, Inc.'s interest receivable on interest rate and cross currency swaps?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s interest receivable on interest rate and cross currency swaps has grown at a 218.6% compound annual growth rate (CAGR), from $6K to $1.97M.